Both in Blank Checks
Vendome Acquisition Corporation I vs Drugs Made In America Acquisition
Over the past year VNME returned +3.3% and DMAA returned +5.6%; their daily moves had a correlation of 0.20.
VNME +3.3% DMAA +5.6%Growth of $1, one year, split-adjusted
| Metric | VNME | DMAA |
|---|---|---|
| Price | $10.35 | $10.89 |
| Market cap | $258.8M | $264.4M |
| Today | +0.29% | 0.00% |
| 1 month | +0.4% | +0.4% |
| 6 months | — | +2.7% |
| Year to date | +3.2% | +5.0% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | -$329.7K |
| Dividend yield | — | — |
| Volatility (60d) | 3.1% | 1.8% |
| Short % of float | 0.2% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).